NASDAQ$BKYI

Bio-key International Inc · Q3 2020 earnings

Q3 2020 earnings · · Investor relations

Briefing

BIO-key reported Q3 revenue and cash position, highlighting the impact of the PortalGuard acquisition and progress in African contracts.

BIO-key reported a significant increase in Q3 revenue, driven by the acquisition of PortalGuard, and ended the quarter with a strong cash position due to a public offering. The company is also seeing progress in its African contracts and expects continued improvement in Q4.

  • BIO-key's Q3 revenue more than doubled year-over-year to $943K, driven by the PortalGuard acquisition.
  • The company ended Q3 with $18.4M in cash following a $24.8 million public offering.
  • PortalGuard saw strong traction, particularly within higher education institutions.
  • Initial progress was made on large projects in Nigeria, with anticipated orders expected in Q4.

Headline financials

Total Revenue

$943K

Previous: $453K+108.4%
EPS (adj)

-$8.64

Previous: -$18.72+53.8%
Gross Margin

78.0%

No prior period
Capital Expenditures

-$6.09K

Previous: -$28.8K+78.8%
Free Cash Flow

-$3.69M

Previous: -$1.91M-93.5%
Net Income

-$3.29M

Previous: -$1.83M-80.0%
Operating Income

-$2.2M

Previous: -$1.27M-73.4%
Gross Profit

$732K

Previous: -$55.9K+1408.1%
Cash & Equivalents

$18.4M

Previous: $78.2K+23411.6%
Total Assets

$24M

Previous: $10.8M+122.6%

Revenue & EPS history

Bio-key · Revenue · Quarterly

$943K

Q3 2020+108.4%vs Q3 2019
Beat estimate in 11 of 16 quarters(69%)
ActualEstimate

Revenue by segment

Bio-key · $943K total across 3 segments · Q3 2020

  • License Fees
    $555K
  • Hardware
    $226K
  • Services
    $162K

Forward guidance

BIO-key expects Q4 performance to continue to improve from Q3 levels, with continued momentum into FY 2021.

Tailwinds

  • Continued momentum into FY 2021.
  • Expected orders of $650K for an initial deployment in Africa in Q4.
  • Normalization of business activity following COVID-19 related challenges.
  • First contract in Nigeria is an approximate $45M project.
  • Building out BIO-key Africa subsidiary to support growth objectives.

Headwinds

  • Lingering business development challenges posed by the COVID-19 pandemic.
  • Projects in Nigeria have been delayed due to the COVID-19 pandemic, and more recently some civil unrest.
  • Civil unrest in Nigeria.
  • Economic disruption from the pandemic.
  • Telecommunications project in Africa is now slated to start in 2021 instead of Q4 2020.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports · overlaid with Q3 2020

Historical avgQ3 2020

-3.5%

Avg return

Earnings day

-5.3%

Avg return

5 days after

-8.9%

Avg return

30 days after

25%

16 / 63 earnings

Positive

+15.9%

Q1 2017

Best reaction

-25.9%

Q3 2016

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+3.7%
Q3 2025-2.2%-4.1%-27.8%
Q1 2025-6.0%-2.5%-2.5%
Q2 2025-1.3%-3.7%-4.9%
Q4 2024-23.6%+2.4%-6.0%
Q3 2024-8.7%-16.5%-5.8%
Q2 2024-12.0%-12.0%+8.5%
Q1 2024-11.8%-10.0%+5.9%
Q4 2025-4.1%-9.5%-15.0%
Q4 2023-4.8%-13.8%-19.0%
Q3 2023-10.6%-15.8%-10.5%
Q2 2023-10.0%-10.0%-27.1%
Q1 2023+5.3%+21.5%+13.8%
Q4 2022-3.0%+8.2%-9.6%
Q3 2022-17.4%-27.1%-45.1%
Q2 2022-17.0%-22.6%-27.6%
Q1 2022-2.0%-6.0%-17.9%
Q4 2021-3.2%-6.0%-14.0%
Q3 2021-8.2%-10.8%-27.5%
Q2 2021-7.4%-5.5%+3.5%
Q1 2021+6.1%+8.4%+32.3%
Q4 2020+2.9%-0.9%-2.6%
Q3 2020-8.7%-4.4%-3.3%
Q2 2020+1.1%-1.4%-36.5%
Q4 2019-24.2%-20.7%-9.8%
Q3 2019-9.2%-12.1%+0.0%
Q2 2019+1.8%-6.8%-29.5%
Q1 2019-6.2%-16.9%-13.1%
Q4 2018-6.8%-4.8%-9.5%
Q3 2018+11.1%+9.3%+13.9%
Q2 2018-2.2%-2.2%-10.4%
Q1 2018-11.0%-1.3%-0.9%
Q4 2017-6.5%+2.0%+7.6%
Q3 2017-10.8%-6.1%-29.1%
Q2 2017-3.1%-4.3%-10.6%
Q1 2017+15.9%+22.0%+17.5%
Q4 2016-7.8%-5.1%-14.1%
Q3 2016-25.9%-7.4%-18.5%
Q2 2016+0.0%-4.2%+8.3%
Q1 2016-5.9%
Q4 2015+0.0%
Q3 2015+0.0%
Q2 2015+5.6%
Q1 2015+0.0%
Q4 2014+0.0%
Q3 2014+0.0%
Q2 2014+0.0%
Q1 2014-3.7%
Q4 2013+7.7%
Q3 2013-10.5%
Q2 2013+3.0%
Q1 2013+9.1%
Q4 2012+0.0%
Q3 2012+14.3%
Q1 2012+14.3%
Q4 2011-9.1%
Q3 2010-15.4%
Q3 2011-15.4%
Q2 2010+9.1%
Q2 2011+9.1%
Q1 2011-6.7%
Q4 2010+0.0%
Q1 2010+0.0%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro